Pharsight

Drugs that contain Pilocarpine Hydrochloride

1. Qlosi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11129812 ORASIS PHARMS Ophthalmic pharmaceutical compositions and uses relating thereto
Aug, 2037

(13 years from now)

US10639297 ORASIS PHARMS Ophthalmic pharmaceutical compositions and uses relating thereto
Aug, 2037

(13 years from now)

US9867810 ORASIS PHARMS Ophthalmic pharmaceutical compositions and uses relating thereto
Aug, 2037

(13 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Oct 17, 2026

Market Authorisation Date: 17 October, 2023

Treatment: Treatment of presbyopia

Dosage: SOLUTION;OPHTHALMIC

More Information on Dosage

QLOSI family patents

Family Patents

2. Vuity patents expiration

VUITY's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11285134 ABBVIE INC Presbyopia treatments
Apr, 2039

(15 years from now)

US10610518 ABBVIE INC Presbyopia treatments
Apr, 2039

(15 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Dosing Schedule (D) Mar 28, 2026
New Product (NP) Oct 28, 2024

Market Authorisation Date: 28 October, 2021

Treatment: Use of vuity for the treatment of presbyopia in adults

Dosage: SOLUTION;OPHTHALMIC

How can I launch a generic of VUITY before it's drug patent expiration?
More Information on Dosage

VUITY family patents

Family Patents